Title : The methionine aminopeptidase 2 inhibitor ZGN-1061 improves glucose control and weight in overweight and obese individuals with type 2 diabetes: A randomized, placebo-controlled trial.

Pub. Date : 2020 Jul

PMID : 32077231






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The methionine aminopeptidase 2 inhibitor ZGN-1061 improves glucose control and weight in overweight and obese individuals with type 2 diabetes: a randomized placebo-controlled trial. Glucose methionyl aminopeptidase 2 Homo sapiens
2 The methionine aminopeptidase 2 (MetAP2) inhibitor ZGN-1061 lowered weight and improved glucose in preclinical studies. Glucose methionyl aminopeptidase 2 Homo sapiens
3 The methionine aminopeptidase 2 (MetAP2) inhibitor ZGN-1061 lowered weight and improved glucose in preclinical studies. Glucose methionyl aminopeptidase 2 Homo sapiens
4 We conclude that MetAP2 inhibition with ZGN-1061 for 12 weeks improved glucose control and aided weight loss in overweight and obese people with type 2 diabetes. Glucose methionyl aminopeptidase 2 Homo sapiens